Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0H7RH
|
|||
Former ID |
DNC013980
|
|||
Drug Name |
ANTIOQUINE
|
|||
Synonyms |
CHEMBL452904; Antioquine (S,R); SCHEMBL6044740
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C37H40N2O6
|
|||
Canonical SMILES |
CN1CCC2=CC(=C3C=C2C1CC4=CC(=C(C=C4)O)C5=C(C=CC(=C5)CC6C7=C(O3)C(=C(C=C7CCN6C)OC)O)OC)OC
|
|||
InChI |
1S/C37H40N2O6/c1-38-12-10-23-18-32(43-4)33-20-25(23)28(38)16-21-6-8-30(40)26(14-21)27-15-22(7-9-31(27)42-3)17-29-35-24(11-13-39(29)2)19-34(44-5)36(41)37(35)45-33/h6-9,14-15,18-20,28-29,40-41H,10-13,16-17H2,1-5H3/t28-,29+/m1/s1
|
|||
InChIKey |
MNNXIEANPHEHSB-WDYNHAJCSA-N
|
|||
CAS Number |
CAS 93767-27-2
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Dopamine transporter (DAT) | Target Info | Inhibitor | [1] |
KEGG Pathway | Dopaminergic synapse | |||
Parkinson's disease | ||||
Cocaine addiction | ||||
Amphetamine addiction | ||||
Alcoholism | ||||
Panther Pathway | Adrenaline and noradrenaline biosynthesis | |||
Parkinson disease | ||||
Dopamine receptor mediated signaling pathway | ||||
Pathway Interaction Database | Alpha-synuclein signaling | |||
Reactome | Na+/Cl- dependent neurotransmitter transporters | |||
WikiPathways | Monoamine Transport | |||
NRF2 pathway | ||||
Dopaminergic Neurogenesis | ||||
Parkinsons Disease Pathway | ||||
Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds | ||||
Neurotransmitter Clearance In The Synaptic Cleft |
References | Top | |||
---|---|---|---|---|
REF 1 | Effects of various isoquinoline alkaloids on in vitro 3H-dopamine uptake by rat striatal synaptosomes. J Nat Prod. 1995 Oct;58(10):1475-84. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.